RxDoctor Payments Data

Hannah Buehler, PA

Physician Assistant · Snellville, GANPI 1780342535

Payments from drug & device makers

$9,929in general payments, 2019–2025

Across 495 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Regeneron Healthcare Solutions, Inc.$1K
  • UCB, Inc.$884
  • Novartis$852
  • Sanofi$724
  • LEO Pharma Inc.$521
  • plus $4K from 22 others

What the payments were for

  • Food & beverage$9,65297%
  • Education$2773%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,929 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$181,837
Medicare patients
604
Services billed
4,696

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab30$109,943
OtezlaApremilast20$97,989
Dupixent SyringeDupilumab19$69,626
Clobetasol Propionate223$10,291
Tacrolimus41$6,005
Doxycycline Hyclate136$4,965
Ketoconazole209$3,905
Fluorouracil50$2,968
Clindamycin Phosphate34$1,346
Mupirocin192$989
Cephalexin81$956
Triamcinolone Acetonide100$922
Betamethasone Dipropionate13$683
Metronidazole15$597
Hydrocortisone94$584

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$59$97,98920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Snellville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →